BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35121343)

  • 1. LCAT- targeted therapies: Progress, failures and future.
    Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant lecithin:cholesterol acyltransferase containing a Thr123-->Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein.
    O K; Hill JS; Wang X; Pritchard PH
    J Lipid Res; 1993 Jan; 34(1):81-8. PubMed ID: 8445345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.
    Freeman LA; Karathanasis SK; Remaley AT
    Curr Opin Lipidol; 2020 Apr; 31(2):71-79. PubMed ID: 32073411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM; Sallee B; Asztalos BF; Pritchard PH; Frohlich J; Schaefer EJ
    J Clin Lipidol; 2014; 8(2):223-30. PubMed ID: 24636183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen S; Van Eck M
    J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; FrascĂ  G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
    Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of Familial LCAT Deficiency in Japan.
    Kuroda M; Bujo H; Yokote K; Murano T; Yamaguchi T; Ogura M; Ikewaki K; Koseki M; Takeuchi Y; Nakatsuka A; Hori M; Matsuki K; Miida T; Yokoyama S; Wada J; Harada-Shiba M
    J Atheroscler Thromb; 2021 Jul; 28(7):679-691. PubMed ID: 33867422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
    Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
    J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
    Freeman LA; Shamburek RD; Sampson ML; Neufeld EB; Sato M; Karathanasis SK; Remaley AT
    J Lipid Res; 2019 May; 60(5):1050-1057. PubMed ID: 30808683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BacMam production of active recombinant lecithin-cholesterol acyltransferase: Expression, purification and characterization.
    Romanow WG; Piper DE; Fordstrom P; Thibault S; Zhou M; Walker NP
    Protein Expr Purif; 2016 Sep; 125():1-6. PubMed ID: 26363122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.
    Rousset X; Vaisman B; Auerbach B; Krause BR; Homan R; Stonik J; Csako G; Shamburek R; Remaley AT
    J Pharmacol Exp Ther; 2010 Oct; 335(1):140-8. PubMed ID: 20605907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
    Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
    Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
    Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.